CA9 and neoplasm: Combinatorial genetic depletion of CA9 and NFS1 expression, or pharmacologic inhibition of CAIX/XII in combination with NFS1 depletion, results in increased cellular iron pools, increased lipid peroxidation and increased ferroptosis of tumour cells (Figure 1) (Chafe et al., 2021).